Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/26/2003US6610658 Modulators of μ-amyloid peptide aggregation
08/26/2003US6610652 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610513 Receptor proteins
08/26/2003US6610512 Zinc finger binding domains for GNN
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610309 Vaccines; mixture of antigen and water solubility organometallic compound
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610283 Poly(diallylamine)-based bile acid sequestrants
08/25/2003CA2419773A1 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/21/2003WO2003069302A2 Alpha-substituted arylalkyl phosphonate derivatives
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068957A1 METHOD OF SCREENING INK4 FAMILY GENE EXPRESSION CONTROLLER AND p19 GENE PROMOTER
08/21/2003WO2003068952A1 Stat3 activated stem cell
08/21/2003WO2003068946A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003WO2003068818A1 Novel glutamate receptor and utilization thereof
08/21/2003WO2003068817A1 Management of mucosal viscosity by tff monomer peptides
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068790A2 Macrolide antibacterial compounds
08/21/2003WO2003068776A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
08/21/2003WO2003068772A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068756A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003WO2003068754A1 Therapeutic substituted indazole derivatives
08/21/2003WO2003068753A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068750A1 Jnk inhibitor
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068746A1 Aryl ureas as kinase inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068725A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068264A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
08/21/2003WO2003068263A1 Remedy for hypertension
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068257A1 Cancer therapy
08/21/2003WO2003068255A1 Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
08/21/2003WO2003068245A1 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
08/21/2003WO2003068244A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
08/21/2003WO2003068241A1 Percutaneous preparations
08/21/2003WO2003068237A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003WO2003068236A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068227A1 5-ht2b receptor antagonists
08/21/2003WO2003068226A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068218A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003068215A1 Drugs for mitochondrial diseases
08/21/2003WO2003068214A1 Novel preventive for infections
08/21/2003WO2003068208A1 Methods of reducing angiogenesis
08/21/2003WO2003068207A2 Partial dopamine-d2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
08/21/2003WO2003068205A1 Compositions and foods for improving lipid metabolism
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003068148A2 Treatment of sleep disorders using sleep target modulators
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003067979A1 Drugs to be used in organ transplantation
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003047579B1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003039479A3 Polymeric thiol-linked prodrugs
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003024404A3 Chemokines as adjuvants of immune response
08/21/2003WO2003020217A3 Novel pyrazole analogs acting on cannabinoid receptors
08/21/2003WO2003008643A3 Methods and polynukleotides for assaying the activity of a dna modifying enzyme
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2003004006A8 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
08/21/2003WO2002100847A3 Factor xa inhibitor
08/21/2003WO2002098459A3 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
08/21/2003WO2002089779A3 Combined preparation for the prophylaxis and/or therapy of nerve cell and/or glia cell damage using a novel method of treatment
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003WO2002067861A3 Oncolytic adenoviral vectors
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002058623A3 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
08/21/2003WO2002050536A3 Replication assay for detecting anti-viral substances
1 ... 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 ... 1564